Equine asthma is characterized by bronchoconstriction and pulmonary inflammation induced by inhaled antigens. In its more common form, susceptible horses become symptomatic when exposed to hay and straw, which contain high levels of fungi, mites, and endotoxins.1,2 Similarly, asthma in humans is associated with exposure to antigens, which are usually proteins, and more specifically to aeroallergens.3 Visibly moldy hay, compared to well-cured hay, is associated with more rapid asthma exacerbations, and horses with fungal particles in their tracheal aspirates are more likely to be diagnosed with equine asthma than those without fungi in their trachea.4 However, fungal spores have been observed in bronchoalveolar lavage fluid (BALF) from horses with and without asthma.5 Some studies have found more antibodies against specific fungi in the serum of horses with severe asthma, including against Aspergillus fumigatus, Alternaria alternata, and Saccharopolyspora rectivirgula.6–9 Other investigators have found higher levels of antibodies against fungi in BALF of asthmatic horses, but not in their blood.10
Human asthma development and exacerbation are associated with higher levels of fungal exposure indoors.11 However, in animal models of asthma, fungal exposure can also be enhanced by allergen-driven type II immune responses, promoting asthma exacerbations independent of previous sensitization to specific fungi.12 Therefore, fungal nonallergenic factors may also be involved in asthma exacerbations and complications. The β-(1, 3)-D-glucans (hereafter, β-glucans) are carbohydrates that account for more than 50% of the fungal cell wall and have been shown to have immunomodulatory activity. In animal models, β-glucans were found to bind predominantly to the innate cell-surface immune receptor dectin-1.12,13 Dectin-1 is a C-type leptin receptor expressed predominantly by dendritic cells and macrophages/monocytes, but is also present on neutrophils, lymphocytes, and in bronchial and alveolar epithelial cells.14–16 Some animal models have shown that fungal β-glucans’ binding to dectin-1 can induce neutrophilic and eosinophilic airway inflammation, and potentially modify endotoxin-induced inflammation, resulting in phagocytic and inflammatory responses through induction of tumor necrosis factor-α, interleukin-6 (IL-6), IL-1β, IL-13, IL-17A, and other mediators.13,17–19 Dectin-1 is a 28-kDa type II membrane protein based on primary sequence analysis, but there is evidence that it is often present as dimers or tetramers in vivo when in contact with β-glucans.20 There are also functional and nonfunctional isoforms of dectin-1, as well as short and long isoforms in mice21 and humans.22 The functional isoforms contain the β-glucan binding domain, WIH, and all isoforms vary slightly in their molecular weight (±10 kDa). To our knowledge, the possible role of dectin-1 in equine asthma has not been studied.
We hypothesized that inhaled fungi are a source of β-glucans that can interact with alveolar macrophages and bronchial epithelial cells via the dectin-1 receptor and contribute to exaggerated pulmonary inflammation in severe equine asthma. To address our hypothesis, we had to establish whether the β-glucan receptor dectin-1 is expressed in the airways of horses and, if so, to determine whether dectin-1 gene expression responded to fungal exposure. Next, we needed to address the question of level and types of fungal exposure when the horses were pastured and stabled. To do this, 3 approaches were used. First, fungal elements in BALF cells were estimated by counting intracellular fungal-like particles in phagocytic cells. Second, an estimate of the total fungal load in BALF samples was made using quantitative PCR (qPCR) assays based on a “universal” fungal probe and primer set. Third, 36 common environmental fungi, including 26 associated with water-damaged materials (group 1) and 10 fungi commonly found outdoors (group 2),23 were quantified in BALF from each horse and in dust samples from the barn using fungal species-specific qPCR assays.
Materials and Methods
Animals
Archived tissues from a previous project stored in the Equine Respiratory Tissue Biobank24 were used. BALF, nasal wash samples, and endobronchial biopsies were collected when 6 horses with well-documented severe asthma and 6 control horses were housed in a grass pasture (remission), and when the same horses had been stabled and fed poor-quality hay for a minimum of 3 weeks (exacerbation)25 (approved by the care committee of University of Montreal [15Rech1760]). Additional archived lung and intestinal tissues were used for Western blot analysis.
Bronchoalveolar lavage processing
BALF total cell counts were obtained with an automated cell counter. Thin-layer cyto-preparations using 200 µL of unfiltered BALF (or 100 µL if the cells were too densely packed) were made and stained with a modified Wright–Giemsa solution. In addition, a few slides were stained with a Grocott’s methenamine silver (GMS) protocol. Differential cell counts were obtained from 400 cells, excluding epithelial cells. The rest of the BALF was centrifuged at 600 X g at 4 °C for 5 minutes, and cells were resuspended in an RNA isolation reagent (TRIzol Reagent; Thermo Fisher Scientific) for later analysis.
The number of macrophages on each cyto-preparation was estimated using the equation: (Cyto-preparation volume [200 µL] X Total cell count/BALF volume) X Macrophage (%). These results were compared to manual counts obtained from 9 cyto-preparation slides in which each macrophage was counted on 25% of the slide surface and multiplied by 4. Because the correlation between the 2 methods was high (Pearson, r = 0.88, P = 0.0019), dectin-1 expression in BALF was later adjusted for the percentage of macrophages obtained in the differential counts.
Endobronchial biopsies
Endobronchial biopsies were obtained using disposable forceps from different branching sites, starting approximately 30 cm distal to the carina and moving cranially.26 The biopsies were fixed in 10% formalin and embedded in paraffin. Four-micrometer slices were made to obtain histological slides.
Measuring total dectin-1 mRNA expression
Total dectin-1 mRNA expression as well as the expression of functional and nonfunctional isoforms were quantified in BALF samples using qPCR assays. The assay primers were designed to span exon–intron boundaries to prevent amplification of genomic DNA (Supplementary Table S1), based on the predicted equine sequences.27 Each primer set generated only 1 PCR product, and the identity and integrity of these products were confirmed by sequencing. Additional primers were also designed to allow for the distinction between functional (X2 and X4) and nonfunctional (X1 and X3) isoforms by including the β-glucan binding domain (WIH) sequence in the amplicon. The protein sequences of the 4 predicted equine isoforms are presented in Supplementary Table S2.
Total RNA extraction from BALF cells was performed using the RNeasy Plus Mini Kit (Qiagen). The adequacy of the RNA concentration and purity for each sample were evaluated spectrophotometrically. From each sample of total mRNA, 500 ng was reverse-transcribed using Superscript III (200 U/µL) in the presence of a recombinant ribonuclease inhibitor (40 U/µL; RNaseOUT, Thermo Fisher Scientific) and oligo(dt) primers (final concentration, 2.5 μM). Samples and a negative control were reverse-transcribed and purified in duplicate. For gene expression studies, samples were processed using a real-time detection system (Rotor-Gene RG3000; Corbett Research), and the amplification was monitored using DNA binding dye (QuantiTect SYBR Green PCR Kit; Qiagen) according to the manufacturer’s instructions, with minor modifications. Samples were run in duplicate with glyceraldehyde 3-phosphate dehydrogenase as an appropriate reference gene for this study, and was observed previously to be stable.28 Briefly, 2 µL cDNA template was added to obtain a 20-µL final reaction volume containing 0.5 μM forward and reverse primers. Amplification conditions included a denaturation step of 10 minutes at 95 °C followed by 45 cycles of denaturation, annealing and elongation, and one melting curve. Concentrations of the target gene cDNA were calculated relative to its standard curve. The number of copies of total, functional, and nonfunctional dectin-1 mRNA expression in BALF was calculated as follows: No. of copies = (Amount • 6.022 X 1023)/(Length • 1 X 109 • 650), where 6.022 X 1023 is Avogadro’s number, and 650 Da is the average mass of 1 bp. Because dectin-1 is expressed primarily by macrophages, copy numbers were corrected for the percentage of macrophages in BALF.
Development of polyclonal antibodies against equine dectin-1
Archived tissues were homogenized in tissue protein extraction reagent (T-PER; Thermo Fisher Scientific) (20 mL for 1 g of tissue) containing EDTA (10 µL for each milliliter of T-PER) and protease/phosphatase inhibitors (10 µL for each milliliter of T-PER). Homogenates were centrifuged at 10,000 X g for 5 minutes at room temperature (RT, approximately 21 °C), and supernatants containing proteins were aliquoted. The proteins recovered were quantified with a fluorescent dye (Qubit; Thermo Fisher Scientific) per manufacturer instructions. Polyclonal antibodies were then created using a peptide built based on the equine sequence DEDGYTQLDFSSRDITRRP present in the X1, X2, X3, and X4 isoforms of the equine dectin-1 receptor (Supplementary Table S2). Two rabbits were immunized using a primary subcutaneous injection of 0.25 mg antigen in complete Freund’s adjuvant, followed by 3 boosters of 0.10 mg antigen in incomplete Freund’s adjuvant, and serum was harvested on day 72, all of which was performed by a commercial laboratory of Thermo Fisher Scientific. Two polyclonal antibodies were initially tested but only 1, AB1250, gave reliable results. Western blot testing was performed on different equine tissues, including lung homogenates, bronchial epithelium cells, BALF cells, intestine homogenates, and intermediate and peripheral bronchial homogenates. The purified peptide used to immunize the rabbits served as a positive control.
The product proteins were analyzed using SDS-PAGE. SDS-PAGE was performed with a 10% precast gel immerged in a Tris-glycine running buffer (25 mM Tris HCl, 192 mM glycine, 0.1% w/v SDS). Migration was carried out at 150 V for 1.5 hours. The gels were then recovered for processing and incubated overnight at 4 °C with the rabbit anti-dectin-1 AB1250 at a 1/500 dilution, and then incubated with a goat anti-rabbit secondary antibody for 1 hour at RT at a 1/2,000 dilution (#7074; Cell Signal). Gels were incubated for 5 minutes at RT in the dark with a chemiluminescence substrate (SuperSignal West Dura; Thermo Fisher Scientific) prepared according to the manufacturer’s instructions.
Detection of dectin-1 on endobronchial biopsy slides by immunohistochemistry
Endobronchial biopsy histological slides were used for the detection of dectin-1. The slides were heated in 1 mM sodium citrate buffer (pH = 6.0) for 30 minutes. Endogenous peroxidase was blocked for 5 minutes at RT with a 3% H2O2–methanol solution. Nonspecific binding of the secondary antibody was blocked by a 0.5-hour incubation at RT of a 10% goat serum solution (Abcam) diluted in PBS containing 1% w/v bovine serum albumin (BSA). The slides were incubated overnight at 4 °C with either the primary antibody anti-dectin-1 AB1250 at a 1/1,000 dilution or preimmunization serum from the same rabbit as a negative control. A goat anti-rabbit secondary antibody (#31822; Thermo Fisher Scientific) prepared in 1% BSA-PBS was incubated at a 1/500 dilution for 1 h at RT. An avidin–biotin–horseradish peroxidase complex (Vector Laboratories) was then added for 45 minutes at RT after 3 washes in PBS, followed by 3,3′-diaminobenzidine (Vector Laboratories) prepared according to manufacturer instructions and added to the specimens for 2 minutes at RT. Slides were counterstained with Harris hematoxylin.
Quantification of fungal-like intracellular particles
At each time point, 1 BALF cyto-preparation per horse was stained using modified Wright Giemsa staining and examined “blindly” by the same person (RGL). The entire slide was screened (between approximately 1,500 and 15,000 macrophages) and each intracellular particle was photographed to avoid duplication. Some slides were also stained using GMS staining, and images were reviewed by ML and CB to exclude debris and what was more likely to be pollen (larger particles). Results are reported as particles per macrophage (using the estimated number of macrophages as described in the earlier section “Bronchoalveolar lavage processing”).
Total fungal load quantification using “universal” fungal qPCR assay
The fungal small ribosomal subunit 18S rRNA gene was used as a “universal” fungal cell marker. The assay primers (forward 5′-AAAGGAATTGACGGAAGGGCA-3′ and reverse 5′-TCACAGACCTGTTATTGCCTC-3′) were designed to amplify the conserved region of the 18S rRNA gene. The number of copies of this gene was quantified to estimate total fungal load in the samples. Extractions were performed using 5 mL BALF and nasal wash, as described previously.25 The qPCR analyses were performed using a real-time detection system (Rotor-Gene RG3000; Corbett Research) and the amplification was monitored using DNA binding dye (QuantiTect SYBR Green PCR Kit) according to the manufacturer’s instructions, with minor modifications. To the amplification reagent mix was added 2 µL of the DNA extract to make a 20-μL final reaction volume containing 0.5 μM forward and reverse primers. Amplification was carried out with a 10-minute denaturation step at 95 °C followed by 55 cycles of denaturation, annealing and elongation, and one melting curve. Copy numbers of the target gene were calculated relative to a standard curve. Samples were run in duplicate with an appropriate negative control.
Specific fungi quantified by qPCR assays
The concentrations of each of the group 1 and group 2 fungi (Supplementary Table S3) were measured in BALF and barn samples using fungal-specific qPCR assays, as described previously.29,30 Briefly, 5 mL BALF was filtered through 300-μm pore-size nylon mesh. The filters were added to a 2-mL bead-beating tube and the DNA was extracted, as described previously.30
Each of the 36 molds was quantified in each extract with qPCR assays, as described earlier.29 The standard qPCR assay contained 1 μL of a mixture of forward and reverse primers at 25 μM each, 12.5 μL of “Universal Master Mix,” 2.5 μL of a 2-mg/mL fraction V BSA, 2.5 μL of a 400-nM TaqMan probe (Applied Biosystems Inc), and 2.5 μL DNA free water. Five microliters of the DNA extract from the sample and this mix were combined. Reactions were performed with thermal cycling conditions consisting of 2 minutes at 50 °C, 10 minutes at 95 °C, followed by 40 cycles of 15 seconds at 95 °C for template denaturation, and 1 minute at 60 °C for probe and primer annealing and primer extension; 5 mg from each of the sieved dust samples were analyzed by a commercial laboratory (Mycometrics LLC). The number of fungal cells/spores was expressed as the number of cell equivalents (CE) per milliliter of BALF sample.
In addition, 3 dust samples were collected from the study barn using an electrostatic cloth by wiping surfaces, 1 from each end and 1 in the middle of the barn. The dust was recovered from the electrostatic cloths, sieved (300-μM pore), and 5 mg of sieve dust was analyzed for the same 36 molds (Supplementary Table S3), as described previously.31 The 36 fungi were quantified by qPCR assays as described earlier for the BALF samples. The average number of fungal cells/spores from the 3 barn samples was expressed as cell equivalents per milligram of dust.
Statistical analyses
Data were analyzed by a repeated-measure two-way ANOVA with “horse-group” as between-subject factor and “time” as within-subject factor. The alpha level was adjusted using the Benjamini-Hochberg method. Normality of the data was verified using the Shapiro-Wilk test. The qPCR data were log-transformed prior to analysis, as indicated. Correlation between the estimated and the manually counted macrophages in BALF was done using the Pearson correlation coefficient. Data were analyzed using a software program (GraphPad Prism, version 9.1.2; GraphPad Software Inc), and P < 0.05 was considered significant.
Results
Dectin-1 mRNA expression and antibody confirmation testing
The primers targeting the total dectin-1 receptor yielded an amplicon of about 100 bp (Supplementary Figure S1), consistent with the 107-bp size expected based on the sequence. The product sequence showed there was 98% homology with the predicted equine sequence. In healthy horses and horses with asthma, total and nonfunctional dectin-1 isoforms were not upregulated in BALF samples. However, there was a significant upregulation of the functional dectin-1 isoforms with stabling (stabling effect: P < 0.001) in both healthy and asthmatic horses (P = 0.01 and P = 0.002, respectively; Figure 1).
Initial tests showed that the AB1250 antibody preparation yielded less background and less nonspecific staining; it was therefore used in the following analyses. Western blot analysis revealed bands of ∼54 kDa, ∼25 to 32 kDa, and ∼16 kDa in equine lung homogenate, bronchial epithelium, BALF cells, and intestinal cells. However, after protocol optimization, only the ∼54-kDa band was present in bronchial epithelium and bronchial homogenate samples. Also present was an ∼2.7-kDa band, which corresponds to the purified peptide used to generate the dectin-1 antibodies and was included here as a positive control (Figure 2).
Using the AB1250 polyclonal antibody, the dectin-1 receptor was localized on bronchial epithelial cells and in cells identified as macrophages (Figure 3). However, the marking intensity was variable and even semiquantitative evaluation could not be performed.
Quantification of fungal-like particles in BALF cells
Horses with asthma had significantly fewer fungal-like particles based on 2-way ANOVA (group effect: P = 0.048, P = 0.014 between controls and asthmatic horses exposed to hay). Nearly all particles observed were intracellular and in macrophages (Figure 4).
Total fungal load in BALF and nasal washes based on qPCR quantification of the universal fungal 18S rRNA gene
The 18S rRNA fungal gene was detected in all BALF and nasal wash samples. In BALF samples, there was a significant interaction effect (group and stabling: P = 0.002) with a significant decrease in fungal load with hay exposure in asthmatic horses (P = 0.004). Fungal loads were also significantly (P < 0.001) less in horses with asthma exposed to hay compared to nonasthmatic horses under the same condition. There was no significant difference in 18S rRNA gene copy numbers in the nasal washes from the same horses (Figure 5).
Quantification of 36 specific fungi using qPCR assays
Only a few of the 36 fungi tested for in BALF samples were measured in numbers greater than 20 CE/mL of BALF. Those fungi with less than 20 CE/mL of BALF sample were not considered further in this analysis. When either asthmatic or nonasthmatic horses were in the pasture, none of the 36 molds were quantified in BALF samples greater than 20 CE/mL. However, when stabled in the barn, nonasthmatic horses had 5 fungal species greater than 20 CE/mL—namely, Eurotium amstelodami, Aspergillus niger, Wallemia sebi, Rhizopus stolonifer, and Mucor species (Supplementary Table S3). There was a significant stabling effect for these fungi (P < 0.001). None of the 36 fungi was significantly greater in the BALF samples from asthmatic horses compared to nonasthmatic horses. The most abundant fungi in BALF of horses in a pasture was Cladosporium herbarum (Figure 6).
In the 3 averaged barn samples, 19 of the 26 group 1 fungi and 8 of the 10 group 2 fungi exceeded 20 CE/mg of dust. Eurotium amstelodami and W. sebi were the most abundant fungi.
Airway neutrophilia and percentages of macrophages
Asthmatic horses housed in the barn and exposure to poor-quality hay showed airway obstruction and BALF neutrophilia, but not in the nonasthmatic horses.25 As expected, this neutrophilia resulted in significantly lower macrophage percentages in the asthmatic horses (group effect: P = 0.017; asthmatic horses compared to healthy horses when exposed to hay: P = 0.016).
Discussion
To our knowledge, this study reports for the first time that the β-glucan receptor dectin-1 is expressed in the airways, BALF cells, and intestinal tissues of horses. Positive immunohistochemical staining was seen on bronchial epithelial cells and cells identified as macrophages in endobronchial biopsies. In horses with and without asthma, the functional isoforms were upregulated after exposure to hay, but not the total dectin-1 or the nonfunctional isoforms.
Dectin-1 is a pattern recognition receptor that, in some animal models, was found to play a role in innate and acquired immunity.18,32 Its main ligands are β-1,3 and β-1,6 glucans, which are carbohydrates found in fungi, plants, and some bacteria.33 This C-type lectin receptor was first discovered on dendritic cells, but it is also expressed by macrophages and other cells in rodents and humans.16,32,34,35 Recognition of β-glucans by dectin-1 can trigger phagocytosis of fungal pathogens, can promote T-helper 2 (Th2) and Th17 immune responses, and, under some circumstances, induce protective inflammatory responses.33,34,36 The different responses observed might depend on the type of β-glucans (or other β-glucan-like molecules), and the cofactors present.34 For instance, dectin-1 activation in a house-dust mite model of asthma enhances the Th2 immune response,37 whereas in a study using Aspergillus versicolor as a source of β-glucans, dectin-1-deficient mice showed an increase in Th2-type allergic airway inflammation.38 Dectin-1 stimulation by β-glucans can also induce Th17 responses.39 Specifically, dectin-1 stimulation enhances IL-17A production by γδ T cells, which could explain in part the upregulation of IL-17 mRNA observed in BALF cells of asthmatic horses exposed to moldy hay.40 Despite the evidence that fungi can trigger equine asthma exacerbations, antibodies against common fungi in the serum and BALF are not always found.6–10 Therefore, the role of fungi in asthma may not be limited to direct sensitization. Fungi may also stimulate innate and nonspecific immunity via pattern recognition receptors, such as dectin-1 and toll-like receptor 2. However, the latter receptor is not increased in horses during stabling,41 which suggests that dectin-1 might be the predominant pattern recognition receptor of fungi in horses.
In our study, we observed an upregulation of the dectin-1 functional isoforms in the lungs of horses exposed to hay, regardless of their disease status (asthmatic or not). This is likely in response to increased levels of β-glucans in the airways, although β-glucans were not measured directly in this study. This upregulation was not associated with a significant increase in phagocytosis in either group, and there were even significantly less intracellular particles in the macrophages of horses with asthma. It is possible that the increase in dectin-1 expression is counterbalanced by an anti-inflammatory (IL-10) profile expressed by alveolar macrophages from horses with severe asthma.42 Results obtained from Western blot analysis showed that the rabbit anti-dectin-1 custom-made antibody AB1250 recognized the equine peptide present in BALF cells, lung homogenates, bronchial epithelium, homogenates from intermediate and peripheral bronchi, as well as in the intestine. The other bands observed in the gel could correspond to oligomers (∼54 kDa), functional or nonfunctional isoforms (∼25-32 kDa), and the monomeric form (∼16 kDa) of the receptor.15 Western blot analysis suggests that the ∼54-kDa oligomers were recognized more easily by the polyclonal antibodies than the monomeric or dimeric forms (Figure 2), but further work is necessary to confirm this and allow for quantification. A molecular weight band between 25 and 32 kDa was expected based on the calculation of the molecular weights of the equine functional and nonfunctional isoforms, but it is known that, for some animals, the dectin-1 receptor’s molecular weight can vary, especially as a result of the presence of glycosylation sites.14,43
Despite marking of dectin-1 on epithelial cells and on some cells identified as macrophages in endobronchial biopsies, we cannot rule out the possibility that dectin-1 is expressed by other cells, and more work should be done to characterize more fully dectin-1 expression in the lungs of horses. Specifically, double marking could be used to make sure that only macrophages are positive for staining (some cells in the endobronchial biopsies had elongated cytoplasm that could resemble fibroblasts), and immunocytochemistry on BALF cells could help determine whether equine neutrophils can express dectin-1 as well.
Horses kept indoors and fed with dusty hay are exposed to large concentrations of respirable dust, endotoxins, and fungal particles.44–46 β-Glucan concentrations are highest when most of the feeding and cleaning activities take place.45 In horses, β-glucan concentrations in barns are associated with increased mast cell proportions in BALF,46 and in people, household β-glucans are associated with respiratory symptoms.13,47 Fungi commonly found in barns include Aspergillus, Mucoraceae, Penicillium, yeasts, and others,44,48 and culture of BALF from horses housed indoors yielded Aspergillus and yeasts in one study.48 The inhalation of 3 common fungi found in hay (Lichtheimia corymbifera, A. fumigatus, and E. amstelodami), alters lung function and increase lung neutrophilia in horses with asthma.49 Both A. fumigatus and E. amstelodami were present in the BALF and barn dust in our study, and both increased in BALF with stabling (along with W. sebi, A. niger, and others).
We were initially surprised that the number of intracellular fungal-like particles were less commonly observed in the macrophages of horses with asthma exposed to hay. This does not appear to be a result of hay avoidance by the asthmatic horses, because nasal fungal loads in asthmatic and nonasthmatic horses were similar. The percentage of macrophages with intracellular fungal-like elements was very small, but because the number of macrophages screened on each cyto-preparation was greater than 1,000 (often more than 10,000), this finding seems robust. Furthermore, the lower number of fungal-like elements in lung macrophages from horses with asthma is consistent with the lower total fungal load in their BALF samples. These 2 observations are also borne out by finding that some specific fungi from groups 1 and 2 were in lower concentrations in BALF samples of stabled-horses with asthma compared stabled nonasthmatic horses. The most likely explanation is that these fungal particles were trapped more proximally in the respiratory track of asthmatic horses as a result of increased mucus, bronchoconstriction, and coughing. This hypothesis is reinforced by finding that there was no significant difference in total fungal load in the BALF samples from pastured asthmatic and nonasthmatic horses. Therefore, it seems that higher levels of fungi indoors can trigger exacerbations in susceptible horses, even if these fungi do not reach their small peripheral airways as easily as they reach the lower airways of healthy horses. This could be explored in the future by collecting bronchial brushings and endobronchial biopsies at different levels of the bronchial tree, and by collecting BALF sooner after exposure to hay, before severe bronchoconstriction develops.
One of the main limitations of our study is the small number of horses in each group. Although the number of horses was limited, previous studies performed on a similar model indicated that a 30% difference between groups should be detected, providing relatively similar variance in most factors. Another limitation to our study was the lack of commercial antibodies against equine dectin-1. Initial attempts to use a commercially available antibody (rabbit polyclonal to dectin-1, synthetic peptide within human dectin-1 aa 70-120 [extracellular], ab140039 [H1009; Sigma-Aldrich]) were unsuccessful. Cross-reactivity of the dectin-1 antibody between human and mouse has been described despite their low homology, with only 72% homology at the DNA level and 61% homology at the protein level.50 Such cross-reactivity was not present with equine dectin, and this led to the production of antibodies via immunization, which only provided a small quantity of polyclonal antibodies and limited our ability to perform more tests.
In conclusion, the β-glucan receptor dectin-1 is expressed in the airways of horses, and the functional isoforms are upregulated with exposure to hay. In addition to being a source of allergens, fungi could increase airway inflammation in horses with asthma via dectin-1-dependent mechanisms. However, β-glucans should be identified chemically and quantified alongside their dectin-1 receptors to understand more fully their role in equine asthma.
Acknowledgments
Funding was provided by the Veterinary Comparative Respiratory Society Research Fund, the Fonds en Santé Équine of the Université de Montréal, and the Natural Sciences and Engineering Research Council of Canada (06090). The funding source did not have any involvement in the study design, data analysis and interpretation, or writing and publication of the manuscript. The authors acknowledge the Respiratory Health Network of the Fonds de recherche du Québec–Santé for the development of the Equine Respiratory Tissue Bank, and Guy Beauchamp for statistical analysis support.
None of the authors have any financial or personal relationship that could influence or bias the content of this article inappropriately.
The U.S. Environmental Protection Agency (EPA) through its Office of Research and Development collaborated in the research described here. Although this work was reviewed by the EPA and approved for publication, it may not necessarily reflect official EPA policy. Mention of tradenames or commercial products does not constitute endorsement or recommendation by the EPA for use
Supplementary Materials
Supplementary materials are posted online at the journal website: avmajournals.avma.org
References
- 1. ↑
Couëtil LL, Cardwell JM, Gerber V, Lavoie J-P, Léguillette R, Richard EA. Inflammatory airway disease of horses: revised consensus statement. J Vet Intern Med. 2016;30(2):503–515. doi:10.1111/jvim.13824.
- 2. ↑
White S, Moore-Colyer M, Marti E, et al. Development of a comprehensive protein microarray for immunoglobulin E profiling in horses with severe asthma. J Vet Intern Med. 2019;33(5):2327–2335. doi:10.1111/jvim.15564.
- 3. ↑
Akar-Ghibril N, Casale T, Custovic A, Phipatanakul W. Allergic endotypes and phenotypes of asthma. J Allergy Clin Immunol Pract. 2020;8(2):429–440. doi:10.1016/j.jaip.2019.11.008.
- 4. ↑
Dauvillier J, Ter Woort F, van Erck-Westergren E. Fungi in respiratory samples of horses with inflammatory airway disease. J Vet Intern Med. 2019;33(2):968–975. doi:10.1111/jvim.15397.
- 5. ↑
Vrins A, Doucet M, Nunez-Ochoa L. A retrospective study of bronchoalveolar lavage cytology in horses with clinical findings of small airway disease. Zentralbl Veterinarmed A. 1991;38(6):472–479. doi:10.1111/j.1439-0442.1991.tb01036.x.
- 6. ↑
Schmallenbach KH, Rahman I, Sasse HH, et al. Studies on pulmonary and systemic Aspergillus fumigatus-specific IgE and IgG antibodies in horses affected with chronic obstructive pulmonary disease (COPD). Vet Immunol Immunopathol. 1998;66(3–4):245–256. doi:S0165-2427(98)00202-5.
- 7.
Eder C, Crameri R, Mayer C, et al. Allergen-specific IgE levels against crude mould and storage mite extracts and recombinant mould allergens in sera from horses affected with chronic bronchitis. Vet Immunol Immunopathol. 2000;73(3–4):241–253. doi:10.1016/s0165-2427(00)00154-9.
- 8.
Kunzle F, Gerber V, Van Der Haegen A, Wampfler B, Straub R, Marti E. IgE-bearing cells in bronchoalveolar lavage fluid and allergen-specific IgE levels in sera from RAO-affected horses. J Vet Med A Physiol Pathol Clin Med. 2007;54(1):40–47. doi:10.1111/j.1439-0442.2007.00870.x.
- 9. ↑
Moran G, Folch H, Araya O, Burgos R, Barria M. Detection of reaginic antibodies against Faenia rectivirgula from the serum of horses affected with recurrent airway obstruction by an in vitro bioassay. Vet Res Commun. 2010;34(8):719–726. doi:10.1007/s11259-010-9440-z.
- 10. ↑
Halliwell RE, McGorum BC, Irving P, Dixon PM. Local and systemic antibody production in horses affected with chronic obstructive pulmonary disease. Vet Immunol Immunopathol. 1993;38(3–4):201–215. doi:10.1016/0165-2427(93)90081-e.
- 11. ↑
Reponen T, Vesper S, Levin L, et al. High environmental relative moldiness index during infancy as a predictor of asthma at 7 years of age. Ann Allergy Asthma Immunol. 2011;107(2):120–126. doi:10.1016/j.anai.2011.04.018.
- 12. ↑
Zhang Z, Biagini Myers JM, Brandt EB, et al. Beta-Glucan exacerbates allergic asthma independent of fungal sensitization and promotes steroid-resistant TH2/TH17 responses. J Allergy Clin Immunol. 2017;139(1):54–65.e58. doi:10.1016/j.jaci.2016.02.031.
- 13. ↑
Douwes J. (1-->3)-Beta-D-glucans and respiratory health: a review of the scientific evidence. Indoor Air. 2005;15(3):160–169. doi:10.1111/j.1600-0668.2005.00333.x.
- 14. ↑
Ariizumi K, Shen GL, Shikano S, et al. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem. 2000;275(26):20157–20167. doi:10.1074/jbc.M909512199.
- 15. ↑
Brown GD, Taylor PR, Reid DM, et al. Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med. 2002;196(3):407–412. doi:10.1084/jem.20020470.
- 16. ↑
Heyl KA, Klassert TE, Heinrich A, et al. Dectin-1 is expressed in human lung and mediates the proinflammatory immune response to nontypeable Haemophilus influenzae. MBio. 2014;5(5):e01492–01414. doi:10.1128/mBio.01492-14.
- 17. ↑
Goodridge HS, Reyes CN, Becker CA, et al. Activation of the innate immune receptor dectin-1 upon formation of a ‘phagocytic synapse’. Nature. 2011;472(7344):471–475. doi:10.1038/nature10071.
- 18. ↑
Hirose K, Ito T, Nakajima H. Roles of dectin-1 in allergic airway inflammation. Crit Rev Immunol. 2017;37(1):15–21. doi:10.1615/CritRevImmunol.2017024718.
- 19. ↑
Hohl TM, Van Epps HL, Rivera A, et al. Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog. 2005;1(3):e30. doi:10.1371/journal.ppat.0010030.
- 20. ↑
Brown J, O’Callaghan CA, Marshall AS, et al. Structure of the fungal beta-glucan-binding immune receptor dectin-1: implications for function. Protein Sci. 2007;16(6):1042–1052. doi:10.1110/ps.072791207.
- 21. ↑
Heinsbroek SE, Taylor PR, Rosas M, et al. Expression of functionally different dectin-1 isoforms by murine macrophages. J Immunol. 2006;176(9):5513–5518. doi:10.4049/jimmunol.176.9.5513.
- 22. ↑
Willment JA, Gordon S, Brown GD. Characterization of the human beta-glucan receptor and its alternatively spliced isoforms. J Biol Chem. 2001;276(47):43818–43823. doi:10.1074/jbc.M107715200.
- 23. ↑
Vesper S. Traditional mould analysis compared to a DNA-based method of mould analysis. Crit Rev Microbiol. 2011;37(1):15–24. doi:10.3109/1040841X.2010.506177.
- 24. ↑
Equine Respiratory Tissue Biobank. Laboratoire de Biologie Cellulaire et Moléculaire Respiratoire of the Université de Montréal. 2021. Accessed July 1, 2019. https://btre.ca/en/.
- 25. ↑
Fillion-Bertrand G, Dickson RP, Boivin R, Lavoie JP, Huffnagle GB, Leclere M. Lung microbiome is influenced by the environment and asthmatic status in an equine model of asthma. Am J Respir Cell Mol Biol. 2019;60(2):189–197. doi:10.1165/rcmb.2017-0228OC.
- 26. ↑
Leclere M, Lavoie-Lamoureux A, Gélinas-Lymburner É, David F, Martin JG, Lavoie J-P. Effect of antigenic exposure on airway smooth muscle remodeling in an equine model of chronic asthma. Am J Respir Cell Mol Biol. 2011;45(1):181–187. doi:10.1165/rcmb.2010-0300OC.
- 27. ↑
NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucl Acids Res. 2018;46(D1):D8–D13. doi:10.1093/nar/gkx1095.
- 28. ↑
Beekman L, Tohver T, Leguillette R. Comparison of cytokine mRNA expression in the bronchoalveolar lavage fluid of horses with inflammatory airway disease and bronchoalveolar lavage mastocytosis or neutrophilia using REST software analysis. J Vet Intern Med. 2012;26(1):153–161. doi:10.1111/j.1939-1676.2011.00847.x.
- 29. ↑
Haugland RA, Vesper SJ. Method of Identifying and Quantifying Specific Fungi and Bacteria. Patent 6387652. U.S. Patent and Trademark Office, Washington, DC; 2002.
- 30. ↑
Haugland RA, Varma M, Wymer LJ, Vesper SJ. Quantitative PCR analysis of selected Aspergillus, Penicillium and Paecilomyces species. Syst Appl Microbiol. 2004;27(2):198–210. doi:10.1078/072320204322881826.
- 31. ↑
Cox J, Indugula R, Vesper S, Zhu Z, Jandarov R, Reponen T. Comparison of indoor air sampling and dust collection methods for fungal exposure assessment using quantitative PCR. Environ Sci Process Impacts. 2017;19(10):1312–1319. doi:10.1039/c7em00257b.
- 32. ↑
Sun W-K, Lu X, Li X, et al. Dectin-1 is inducible and plays a crucial role in Aspergillus-induced innate immune responses in human bronchial epithelial cells. Eur J Clin Microbiol Infect Dis. 2012;31(10):2755–2764. doi:10.1007/s10096-012-1624-8.
- 33. ↑
Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol. 2006;6(1):33–43. doi:10.1038/nri1745.
- 34. ↑
Hadebe S, Brombacher F, Brown GD. C-type lectin receptors in asthma. Front Immunol. 2018;9:733. doi:10.3389/fimmu.2018.00733.
- 35. ↑
Liu ZC, Wang M, Sun WK, et al. Up-regulation of dectin-1 in airway epithelial cells promotes mice defense against invasive pulmonary aspergillosis. Int J Clin Exp Med. 2015;8(10):17489–17497. eCollection 2015
- 36. ↑
Peng XD, Zhao GQ, Lin J, et al. Fungus induces the release of IL-8 in human corneal epithelial cells, via dectin-1-mediated protein kinase C pathways. Int J Ophthalmol. 2015;8(3):441–447. doi:10.3980/j.issn.2222-3959.2015.03.02.
- 37. ↑
Ito T, Hirose K, Norimoto A, Saku A, Nakajima H. Dectin-1 plays a critical role in HDM-induced PGE2 production in macrophages. Allergol Int. 2017;66S:S44–S46. doi:10.1016/j.alit.2017.05.001.
- 38. ↑
Mintz-Cole RA, Gibson AM, Bass SA, Budelsky AL, Reponen T, Hershey GK. Dectin-1 and IL-17A suppress murine asthma induced by Aspergillus versicolor but not Cladosporium cladosporioides due to differences in beta-glucan surface exposure. J Immunol. 2012;189(7):3609–3617. doi:10.4049/jimmunol.1200589.
- 39. ↑
LeibundGut-Landmann S, Gross O, Robinson MJ, et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol. 2007;8(6):630–638. doi:10.1038/ni1460.
- 40. ↑
Debrue M, Hamilton E, Joubert P, Lajoie-Kadoch S, Lavoie JP. Chronic exacerbation of equine heaves is associated with an increased expression of interleukin-17 mRNA in bronchoalveolar lavage cells. Vet Immunol Immunopathol. 2005;105(1–2):25–31. doi:10.1016/j.vetimm.2004.12.013.
- 41. ↑
Berndt A, Derksen FJ, Venta PJ, et al. Expression of toll-like receptor 2 mRNA in bronchial epithelial cells is not induced in RAO-affected horses. Equine Vet J. 2009;41(1):76–81. doi:10.2746/042516408x347592.
- 42. ↑
Wilson ME, McCandless EE, Olszewski MA, Robinson NE. Alveolar macrophage phenotypes in severe equine asthma. Vet J. 2020;256:105436. doi:10.1016/j.tvjl.2020.105436.
- 43. ↑
Kato Y, Adachi Y, Ohno N. Contribution of N-linked oligosaccharides to the expression and functions of beta-glucan receptor, dectin-1. Biol Pharm Bull. 2006;29(8):1580–1586. doi:10.1248/bpb.29.1580.
- 44. ↑
Nardoni S, Mancianti F, Sgorbini M, Taccini F, Corazza M. Identification and seasonal distribution of airborne fungi in three horse stables in Italy. Mycopathologia. 2005;160(1):29–34. doi:10.1007/s11046-005-2669-3.
- 45. ↑
Samadi S, Wouters IM, Houben R, Jamshidifard AR, Van Eerdenburg F, Heederik DJ. Exposure to inhalable dust, endotoxins, beta(1-->3)-glucans, and airborne microorganisms in horse stables. Ann Occup Hyg. 2009;53(6):595–603. doi:10.1093/annhyg/mep040.
- 46. ↑
Ivester KM, Couetil LL, Moore GE. An observational study of environmental exposures, airway cytology, and performance in racing thoroughbreds. J Vet Intern Med. 2018;32(5):1754–1762. doi:10.1111/jvim.15226.
- 47. ↑
Schram-Bijkerk D, Doekes G, Douwes J, et al. PARSIFAL Study Group, Bacterial and fungal agents in house dust and wheeze in children: the PARSIFAL Study. Clin Exp Allergy. 2005;35(10):1272–1278. doi:10.1111/j.1365-2222.2005.02339.x.
- 48. ↑
Ferro E, Ferrucci F, Salimei E, Antonin M, Codazza D, Caniatti M. Relationship between the conditions of lower airways in healthy horses, environmental factors and air quality in stables. Pferdeheilkunde. 2000;16(6):579–586. doi:10.21836/PEM20000603.
- 49. ↑
Beeler-Marfisi J, Clark ME, Wen X, et al. Experimental induction of recurrent airway obstruction with inhaled fungal spores, lipopolysaccharide, and silica microspheres in horses. Am J Vet Res. 2010;71(6):682–689. doi:10.2460/ajvr.71.6.682.
- 50. ↑
Sattler S, Ghadially H, Hofer E. Evolution of the C-type lectin-like receptor genes of the dectin-1 cluster in the NK gene complex. Sci World J. 2012;2012:931386. doi:10.1100/2012/931386.